Literature DB >> 16824748

Mutational analysis of the hCDC4 gene in gastric carcinomas.

J W Lee1, Y H Soung, H J Kim, W S Park, S W Nam, S H Kim, J Y Lee, N J Yoo, S H Lee.   

Abstract

hCDC4, a ubiquitin ligase, plays a role in the control of cell cycle and chromosome stability. The hCDC4 gene is considered a tumour suppressor gene and is mutated in several human neoplasias, including colorectal and endometrial tumours. Data on the hCDC4 mutation in gastric cancer is, however, lacking. This study explored the possibility that hCDC4 mutation is involved in the development of gastric cancer. The hCDC4 gene in 162 gastric adenocarcinoma tissues was analysed for somatic mutations using a polymerase chain reaction-single strand conformation polymorphism assay. Overall, six hCDC4 mutations were found (3.7%), comprising four missense, one frameshift deletion and one nonsense mutation(s). It is notable that the hCDC4 mutations were found in early as well as in advanced gastric carcinomas. These data indicate that hCDC4 mutation occasionally occurs in gastric carcinomas and suggest that it might play a role in the development of some gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824748     DOI: 10.1016/j.ejca.2005.10.034

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.

Authors:  Jinhai Li; Yuanyuan Guo; Xiaodi Liang; Ming Sun; Guoliang Wang; Wei De; Wenxi Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-22       Impact factor: 4.553

2.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.

Authors:  Ichiro Onoyama; Atsushi Suzuki; Akinobu Matsumoto; Kengo Tomita; Hideki Katagiri; Yuichi Oike; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

3.  MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.

Authors:  Chi-Hsiang Chiang; Pei-Yi Chu; Ming-Feng Hou; Wen-Chun Hung
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

4.  Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.

Authors:  Jingxiao Wang; Haichuan Wang; Michele Peters; Ning Ding; Silvia Ribback; Kirsten Utpatel; Antonio Cigliano; Frank Dombrowski; Meng Xu; Xinyan Chen; Xinhua Song; Li Che; Matthias Evert; Antonio Cossu; John Gordan; Yong Zeng; Xin Chen; Diego F Calvisi
Journal:  J Hepatol       Date:  2019-06-11       Impact factor: 25.083

Review 5.  The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.

Authors:  Alan W Lau; Hidefumi Fukushima; Wenyi Wei
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

Review 6.  Regulation of stem cell function by protein ubiquitylation.

Authors:  Alexandros Strikoudis; Maria Guillamot; Iannis Aifantis
Journal:  EMBO Rep       Date:  2014-03-20       Impact factor: 8.807

Review 7.  Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.

Authors:  Huizhen Wang; Yida Lu; Mingliang Wang; Youliang Wu; Xiaodong Wang; Yongxiang Li
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

8.  FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors.

Authors:  Denis L Jardim; Jennifer J Wheler; Kenneth Hess; Apostolia M Tsimberidou; Ralph Zinner; Filip Janku; Vivek Subbiah; Aung Naing; Sarina A Piha-Paul; Shannon N Westin; Sinchita Roy-Chowdhuri; Funda Meric-Bernstam; David S Hong
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 9.  Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.

Authors:  Jun Cao; Ming-Hua Ge; Zhi-Qiang Ling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.

Authors:  Antoine M Snijders; Yueyong Liu; Li Su; Yurong Huang; Jian-Hua Mao
Journal:  Oncotarget       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.